Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://link.springer.com/article/10.1007/s00210-025-04078-y, but it redirected us to https://link.springer.com/article/10.1007/s00210-025-04078-y. The analysis below is for the second page.

Title[redir]:
The effects of flavonoid baicalein on miRNA expressions in cancer: a systematic review | Naunyn-Schmiedeberg's Archives of Pharmacology
Description:
Baicalein from Scutellaria baicalensis influences miRNA expression in various cancers, affecting key signaling pathways (PI3K/AKT, Wnt/β-catenin, mTOR) and processes like tumor growth, apoptosis, and metastasis. miRNAs, as small non-coding RNAs, play crucial roles in the cancer pathogenesis-associated gene regulations. This study is aimed at systematically reviewing the effects of baicalein on miRNA expression in various cancers. A comprehensive systematic review was conducted following PRISMA guidelines to investigate the impact of baicalein on miRNA expression in cancer. Databases including PubMed, Scopus, and Web of Science were systematically searched using key search terms. Inclusion criteria encompassed studies reporting changes in miRNA expression following baicalein treatment in cancer cell lines and animal models. Data extraction and risk of bias assessment based on SYRCLE’s risk of bias tool were performed to ensure methodological rigor and reliability of the findings. Fifteen studies meeting the inclusion criteria were included in the systematic review. Baicalein impacts miRNA expression in cancers like hepatocellular carcinoma, breast, cervical, ovarian, and gastric cancers, suggesting its potential as a multi-cancer therapeutic. Baicalein regulates tumor-related genes (HDAC10, MDM2, Bcl-2/Bax, and Cyclin E1) and signaling molecules (AKT, FOXO3α), affecting cell viability, apoptosis, and cell cycle, indicating targeted therapeutic potential. In vitro and in vivo studies show baicalein inhibits tumor growth, enhances apoptosis, and regulates cell proliferation, supporting its anticancer effects. Baicalein exhibits potential in modulating miRNA expression in cancer, offering avenues for therapeutic intervention. However, methodological rigor in future studies is essential to enhance the reliability and validity of findings. Comprehensive understanding of baicalein’s effects on miRNA expression holds promise for developing novel cancer treatment strategies.

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Science

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🏙️ Massive Traffic: 50M - 100M visitors per month


Based on our best estimate, this website will receive around 80,904,851 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We don't see any clear sign of profit-making.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Doi.org might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

pubmed, article, google, scholar, cas, cancer, central, baicalein, cell, wang, signaling, cells, pathway, expression, res, zhang, protein, sci, med, mol, chen, effects, cervical, therapeutic, khan, zhao, liu, mirna, cancers, targeting, review, apoptosis, anticancer, yang, biol, data, bagheri, tumor, growth, carcinoma, breast, subramaniyan, int, zhu, systematic, inhibits, access, ther, clin, front,

Topics {✒️}

tgf-β/lncrna-malat1/mir-200c signaling pathway regulating mir-3127-5p/fzd4/wnt/β-catenin signaling wnt/beta-catenin/tcf signaling induces regulating mir-150-5p/zbtb4 axis wnt/β-catenin pathway circhiat1/mir-19a-3p axis pi3k/akt/mtor signaling regulates month download article/chapter targeting pten/pi3k/akt pathway wnt/β-catenin egfr/erk/ap-1 pathway natural anti-cancer compound jak2/stat3 signaling pathway pi3k/akt signaling cascade jak/stat signal pathway downstream pi3k/akt pathway blocking akt/mtor pathway interleukin-17 activates jak2/stat3 ferm-enhanced p53 degradation streptozotocin-induced diabetic rats microrna-301b-3p accelerates suppressing pd-l1 expression regulating mir-206/rap1b pathway janus kinase-signal transducer inhibiting pi3k/akt pathway aging-related vascular diseases single-stranded cleavage site anti-breast cancer molecule wnt signaling pathway virus/host cell crosstalk compartment-specific target proteins databases including pubmed article naunyn-schmiedeberg' immunogenetics research center seyed mostafa rahimi systems biology approaches computational proteome-wide study estrogen receptor-alpha frizzled linker domain full article pdf tumor protein d52 article khandan mir-196b-5p anti-tumor immunity khazeei tabari ma regulates cell proliferation baicalein induces apoptosis privacy choices/manage cookies akt/pkb signaling critical signaling pathways

Questions {❓}

  • Macedo F, Ladeira K, Longatto-Filho A, Martins SF (2017) Gastric cancer and angiogenesis: is VEGF a useful biomarker to assess progression and remission?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:The effects of flavonoid baicalein on miRNA expressions in cancer: a systematic review
         description:Baicalein from Scutellaria baicalensis influences miRNA expression in various cancers, affecting key signaling pathways (PI3K/AKT, Wnt/β-catenin, mTOR) and processes like tumor growth, apoptosis, and metastasis. miRNAs, as small non-coding RNAs, play crucial roles in the cancer pathogenesis-associated gene regulations. This study is aimed at systematically reviewing the effects of baicalein on miRNA expression in various cancers. A comprehensive systematic review was conducted following PRISMA guidelines to investigate the impact of baicalein on miRNA expression in cancer. Databases including PubMed, Scopus, and Web of Science were systematically searched using key search terms. Inclusion criteria encompassed studies reporting changes in miRNA expression following baicalein treatment in cancer cell lines and animal models. Data extraction and risk of bias assessment based on SYRCLE’s risk of bias tool were performed to ensure methodological rigor and reliability of the findings. Fifteen studies meeting the inclusion criteria were included in the systematic review. Baicalein impacts miRNA expression in cancers like hepatocellular carcinoma, breast, cervical, ovarian, and gastric cancers, suggesting its potential as a multi-cancer therapeutic. Baicalein regulates tumor-related genes (HDAC10, MDM2, Bcl-2/Bax, and Cyclin E1) and signaling molecules (AKT, FOXO3α), affecting cell viability, apoptosis, and cell cycle, indicating targeted therapeutic potential. In vitro and in vivo studies show baicalein inhibits tumor growth, enhances apoptosis, and regulates cell proliferation, supporting its anticancer effects. Baicalein exhibits potential in modulating miRNA expression in cancer, offering avenues for therapeutic intervention. However, methodological rigor in future studies is essential to enhance the reliability and validity of findings. Comprehensive understanding of baicalein’s effects on miRNA expression holds promise for developing novel cancer treatment strategies.
         datePublished:2025-03-28T00:00:00Z
         dateModified:2025-03-28T00:00:00Z
         pageStart:1
         pageEnd:18
         sameAs:https://doi.org/10.1007/s00210-025-04078-y
         keywords:
            Cancer
            MiRNA
            Flavonoid
            Baicalein
            Pharmacology/Toxicology
            Neurosciences
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00210-025-04078-y/MediaObjects/210_2025_4078_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00210-025-04078-y/MediaObjects/210_2025_4078_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00210-025-04078-y/MediaObjects/210_2025_4078_Fig3_HTML.png
         isPartOf:
            name:Naunyn-Schmiedeberg's Archives of Pharmacology
            issn:
               1432-1912
               0028-1298
            type:
               Periodical
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Mohanna Khandan
               affiliation:
                     name:Mazandaran University of Medical Sciences
                     address:
                        name:Mazandaran University of Medical Sciences, Sari, Iran
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mohammad Amin Khazeei Tabari
               affiliation:
                     name:Mazandaran University of Medical Sciences
                     address:
                        name:Mazandaran University of Medical Sciences, Sari, Iran
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Seyed Mostafa Rahimi
               affiliation:
                     name:Mazandaran University of Medical Sciences
                     address:
                        name:Imam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Iran
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mahmoud Hassani
               affiliation:
                     name:Shahid Beheshti University of Medical Sciences
                     address:
                        name:Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Abouzar Bagheri
               url:http://orcid.org/0000-0001-8040-5056
               affiliation:
                     name:Mazandaran University of Medical Sciences
                     address:
                        name:Imam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Iran
                        type:PostalAddress
                     type:Organization
                     name:Mazandaran University of Medical Sciences
                     address:
                        name:Immunogenetics Research Center, Department of Clinical Biochemistry and Medical Genetics, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:The effects of flavonoid baicalein on miRNA expressions in cancer: a systematic review
      description:Baicalein from Scutellaria baicalensis influences miRNA expression in various cancers, affecting key signaling pathways (PI3K/AKT, Wnt/β-catenin, mTOR) and processes like tumor growth, apoptosis, and metastasis. miRNAs, as small non-coding RNAs, play crucial roles in the cancer pathogenesis-associated gene regulations. This study is aimed at systematically reviewing the effects of baicalein on miRNA expression in various cancers. A comprehensive systematic review was conducted following PRISMA guidelines to investigate the impact of baicalein on miRNA expression in cancer. Databases including PubMed, Scopus, and Web of Science were systematically searched using key search terms. Inclusion criteria encompassed studies reporting changes in miRNA expression following baicalein treatment in cancer cell lines and animal models. Data extraction and risk of bias assessment based on SYRCLE’s risk of bias tool were performed to ensure methodological rigor and reliability of the findings. Fifteen studies meeting the inclusion criteria were included in the systematic review. Baicalein impacts miRNA expression in cancers like hepatocellular carcinoma, breast, cervical, ovarian, and gastric cancers, suggesting its potential as a multi-cancer therapeutic. Baicalein regulates tumor-related genes (HDAC10, MDM2, Bcl-2/Bax, and Cyclin E1) and signaling molecules (AKT, FOXO3α), affecting cell viability, apoptosis, and cell cycle, indicating targeted therapeutic potential. In vitro and in vivo studies show baicalein inhibits tumor growth, enhances apoptosis, and regulates cell proliferation, supporting its anticancer effects. Baicalein exhibits potential in modulating miRNA expression in cancer, offering avenues for therapeutic intervention. However, methodological rigor in future studies is essential to enhance the reliability and validity of findings. Comprehensive understanding of baicalein’s effects on miRNA expression holds promise for developing novel cancer treatment strategies.
      datePublished:2025-03-28T00:00:00Z
      dateModified:2025-03-28T00:00:00Z
      pageStart:1
      pageEnd:18
      sameAs:https://doi.org/10.1007/s00210-025-04078-y
      keywords:
         Cancer
         MiRNA
         Flavonoid
         Baicalein
         Pharmacology/Toxicology
         Neurosciences
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00210-025-04078-y/MediaObjects/210_2025_4078_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00210-025-04078-y/MediaObjects/210_2025_4078_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00210-025-04078-y/MediaObjects/210_2025_4078_Fig3_HTML.png
      isPartOf:
         name:Naunyn-Schmiedeberg's Archives of Pharmacology
         issn:
            1432-1912
            0028-1298
         type:
            Periodical
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Mohanna Khandan
            affiliation:
                  name:Mazandaran University of Medical Sciences
                  address:
                     name:Mazandaran University of Medical Sciences, Sari, Iran
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mohammad Amin Khazeei Tabari
            affiliation:
                  name:Mazandaran University of Medical Sciences
                  address:
                     name:Mazandaran University of Medical Sciences, Sari, Iran
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Seyed Mostafa Rahimi
            affiliation:
                  name:Mazandaran University of Medical Sciences
                  address:
                     name:Imam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Iran
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mahmoud Hassani
            affiliation:
                  name:Shahid Beheshti University of Medical Sciences
                  address:
                     name:Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Abouzar Bagheri
            url:http://orcid.org/0000-0001-8040-5056
            affiliation:
                  name:Mazandaran University of Medical Sciences
                  address:
                     name:Imam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Iran
                     type:PostalAddress
                  type:Organization
                  name:Mazandaran University of Medical Sciences
                  address:
                     name:Immunogenetics Research Center, Department of Clinical Biochemistry and Medical Genetics, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical"]:
      name:Naunyn-Schmiedeberg's Archives of Pharmacology
      issn:
         1432-1912
         0028-1298
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Mazandaran University of Medical Sciences
      address:
         name:Mazandaran University of Medical Sciences, Sari, Iran
         type:PostalAddress
      name:Mazandaran University of Medical Sciences
      address:
         name:Mazandaran University of Medical Sciences, Sari, Iran
         type:PostalAddress
      name:Mazandaran University of Medical Sciences
      address:
         name:Imam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Iran
         type:PostalAddress
      name:Shahid Beheshti University of Medical Sciences
      address:
         name:Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
         type:PostalAddress
      name:Mazandaran University of Medical Sciences
      address:
         name:Imam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Iran
         type:PostalAddress
      name:Mazandaran University of Medical Sciences
      address:
         name:Immunogenetics Research Center, Department of Clinical Biochemistry and Medical Genetics, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Mohanna Khandan
      affiliation:
            name:Mazandaran University of Medical Sciences
            address:
               name:Mazandaran University of Medical Sciences, Sari, Iran
               type:PostalAddress
            type:Organization
      name:Mohammad Amin Khazeei Tabari
      affiliation:
            name:Mazandaran University of Medical Sciences
            address:
               name:Mazandaran University of Medical Sciences, Sari, Iran
               type:PostalAddress
            type:Organization
      name:Seyed Mostafa Rahimi
      affiliation:
            name:Mazandaran University of Medical Sciences
            address:
               name:Imam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Iran
               type:PostalAddress
            type:Organization
      name:Mahmoud Hassani
      affiliation:
            name:Shahid Beheshti University of Medical Sciences
            address:
               name:Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
               type:PostalAddress
            type:Organization
      name:Abouzar Bagheri
      url:http://orcid.org/0000-0001-8040-5056
      affiliation:
            name:Mazandaran University of Medical Sciences
            address:
               name:Imam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Iran
               type:PostalAddress
            type:Organization
            name:Mazandaran University of Medical Sciences
            address:
               name:Immunogenetics Research Center, Department of Clinical Biochemistry and Medical Genetics, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Mazandaran University of Medical Sciences, Sari, Iran
      name:Mazandaran University of Medical Sciences, Sari, Iran
      name:Imam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Iran
      name:Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
      name:Imam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Iran
      name:Immunogenetics Research Center, Department of Clinical Biochemistry and Medical Genetics, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(411)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • AOS
  • Clipboard.js
  • Particles.js
  • Prism.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Crossref

5.05s.